Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Melanoma and MAPK Pathways

20 ta ish

  1. Kanzonol-Z

    Shakhnoza S. Azimova, Valentina I. Vinogradova

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  2. Kanzonol-J

    Shakhnoza S. Azimova, Valentina I. Vinogradova

    BobPlant-based Medicinal Research20120 iqtibos
    ABI

  3. Kanzonol-T

    Shakhnoza S. Azimova, Valentina I. Vinogradova

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  4. Difillinin monoacetyl

    Shakhnoza S. Azimova, Валентина И. Виноградова

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  5. Kanzonol-N

    Shakhnoza S. Azimova, Валентина И. Виноградова

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  6. Ormocarpin (R1=Glc, R2=R3=H)

    Shakhnoza S. Azimova, Валентина И. Виноградова

    BobMetal complexes synthesis and properties20120 iqtibos
    ABI

  7. Licopyranocoumarin

    Shakhnoza S. Azimova, Валентина И. Виноградова

    BobUrticaria and Related Conditions20120 iqtibos
    ABI

  8. Kanzonol-B

    Shakhnoza S. Azimova, Валентина И. Виноградова

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  9. Kanzonol-M

    Shakhnoza S. Azimova, Valentina I. Vinogradova

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  10. Septentriosine

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  11. Kanzonol-G

    Shakhnoza S. Azimova, Valentina I. Vinogradova

    BobCytokine Signaling Pathways and Interactions20120 iqtibos
    ABI

  12. Kanzonol-U

    Shakhnoza S. Azimova, Valentina I. Vinogradova

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  13. Kanzonol-R

    Shakhnoza S. Azimova, Валентина И. Виноградова

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  14. Kanzonol-O

    Shakhnoza S. Azimova, Valentina I. Vinogradova

    BobCancer Treatment and Pharmacology20120 iqtibos
    ABI

  15. Isoderron

    Shakhnoza S. Azimova, Валентина И. Виноградова

    BobMelanoma and MAPK Pathways20120 iqtibos
    ABI

  16. Time to Procedure, Nuclear Imaging and Clinicopathological Characteristics as Predictive Factors for Sentinel Lymph Node Metastasis in Cutaneous Melanoma

    Ljiljana Jauković, Milica Rajović, Lidija Kandolf Sekulović +5

    MaqolaCutaneous Melanoma Detection and ManagementAnnals of Plastic Surgery20180 iqtibos
    ABI

  17. ENCSR784GKB

    A Boyle

    BoshqaOchiq kirishMelanoma and MAPK PathwaysENCODE Datasets20220 iqtibos
    ABI

  18. ENCSR054GKB

    A Boyle

    BoshqaOchiq kirishMelanoma and MAPK PathwaysENCODE Datasets20220 iqtibos
    ABI

  19. Identification of <scp>mitogen‐activated</scp> protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies

    Bandar Alharbi, Lina I. Alnajjar, Hassan H. Alhassan +7

    MaqolaMelanoma and MAPK PathwaysJournal of Molecular Recognition20230 iqtibos
    ABI

  20. Tubulin-Targeted Therapy in Melanoma Increases Cell Invasive Potential by Activation of Actomyosin Cytoskeleton – an <i>in vitro</i> study

    Marcin Luty, Renata Szydlak, Joanna Pabijan +6

    PreprintViral Infectious Diseases and Gene Expression in InsectsbioRxiv (Cold Spring Harbor Laboratory)20240 iqtibos
    ABI